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Uncontrolled proliferation and abnormal cell migration are two of the main characteristics of tumour
growth. Of ultimate importance is the question what are the mechanisms that trigger the progression
from benign neoplasms (uncontrolled/autonomous proliferation) to malignant invasive tumours (high
migration). In the following, we challenge the currently prevailing view that the emergence of invasive-
ness is mainly the consequence of acquired cancer cell mutations. To study this, we mainly focus on
the ‘glioblastoma multiforme’ (GBM) tumour which is a particularly aggressive and invasive tumour. In
particular, with the help of a simple growth model, we demonstrate that the short time required for the
recurrence of a GBM tumour after a gross total resection cannot be deduced solely from a mutation-based
theory. We propose that the transition to invasive tumour phenotypes can be explained on the basis of the
microscopic ‘Go or Grow’ mechanism (migration/proliferation dichotomy) and the oxygen shortage, i.e.
hypoxia, in the environment of a growing tumour. We test this hypothesis with the help of a lattice-gas
cellular automaton. Finally, we suggest possible therapies that could help prevent the progression towards
malignancy and invasiveness of benign tumours.
Keywords: migration/proliferation dichotomy; glioblastoma multiforme; tumour progression; invasion;
hypoxia; lattice-gas cellular automata; mean-field approximation.
1. Introduction
Cancer progression can be described as a sequence of traits or phenotypes that cells have to acquire if
a neoplasm (benign tumour) is to become an invasive and malignant cancer. A phenotype characterizes
c© The author 2010. Published by Oxford University Press on behalf of the Institute of Mathematics and its Applications. All rights reserved.
50 H. HATZIKIROU ET AL.
any kind of observed morphology, function or behaviour of a living cell. Hanahan & Weinberg (2000)
have identified six cancer cell phenotypes, which are characterized by unlimited proliferative potential,
environmental independence of growth, evasion of apoptosis, angiogenesis, high motility rates (inva-
sion) and metastasis. Recently, Fang et al. (2008) have proposed further possible cancer cell phenotypes
such as the hypoxic one.
It is widely believed that tumour cells change their phenotype due to mutations that are acquired
during cancer progression. Initially, mutations alter the proliferation control of the cells which leads to
uncontrolled cell division (Hanahan & Weinberg, 2000). Then, the transformed cells form a neoplastic
lesion and the tumour can grow up to a size at which the diffusion-driven oxygen supply becomes
insufficient (hypoxia) to support further growth. Furthermore, the hypoxic environment and the high
mutational rates of tumour cells, due to their damaged genetic material, may lead to the emergence
of phenotypes characterized by anaerobic metabolism (Gatenby & Gillies, 2004), high motility or/and
angiogenesis. These new attributes allow the tumour to grow further and at this stage metastases are
often observed. The important difference between cells in benign (composed mainly of tumour cells
with a proliferative phenotype) and malignant tumours is the presence of cells with increased motility
in the latter (Giese et al., 2003). Since the emergence of a motile tumour cell population is so important
for tumour progression towards malignancy, we are interested in the conditions that drive the transition
from the proliferative to the motile phenotype.
The principle question that we attempt to answer is which are the cellular mechanisms that promote
the emergence of an invasive tumour phenotype at the expense of a proliferative one. The prevailing view
concerning the emergence of invasive, or any other, phenotype is mutation based. Random mutations
of the appropriate combination of genes can switch the phenotype from a proliferative to an invasive one
(or can trigger any other phenotypic change). In Section 2, we show that only mutation-driven
phenotypic changes are not sufficient to explain the typically fast evolution and the rapid adaptation of
tumours, such as ‘glioblastoma multiforme’ (GBM or simply glioma tumours). Therefore, there is a need
for an alternative hypothesis.
Experiments with cultures of glioma cells (Giese et al., 2003) have shown a relationship between
migratory and proliferative behaviour. Especially, cell motion and proliferation are mutually exclusive
processes since highly motile glioma cells tend to have lower proliferation rates, i.e. cells proliferate
only when they do not move (resting phase). This phenomenon is known as migration/proliferation
dichotomy (or ‘Go or Grow’ mechanism) (Giese et al., 1996a,b). Biological evidence indicates that mi-
gratory and proliferative processes share common signalling pathways, suggesting a unique intracellular
mechanism that regulates both behaviours (Giese et al., 2003). Recently, in Godlewski et al. (2010), the
authors have identified a protein that is responsible for the regulation of migration and proliferation
pathways according to the metabolic stress. This publication provides strong evidences for the existence
and the details of ‘Go or Grow’ mechanism in glioma cells.
In the light of the aforementioned biological observations, we propose an alternative explanation,
based on phenotypic plasticity that challenges the dominant hypothesis that mutations primarily trigger
the switch from a proliferative phenotype to an invasive one. In particular, the response of a microscopic
intracellular mechanism, such as ‘Go or Grow’, to oxygen shortage (hypoxia) may be responsible for
the transition from a highly proliferative to an invasive phenotype in a growing tumour (Fig. 1).
Recently, several studies have investigated the influence of the migration/proliferation dichotomy for
tumour invasion. Athale et al. (2006) have proposed an agent-based model to test the effect of a potential
regulatory network related to the ‘Go or Grow’ mechanism in the emergence of invasive phenotypes.
A lattice-based game theoretical approach (Mansury et al., 2006), involving motile and proliferative
populations, has been used to investigate the dynamics of tumour growth. Fedotov & Iomin (2007) have
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FIG. 1. This sketch shows how the oxygen concentration influences the phenotype of a tumour cell. Cells respond to low oxy-
gen supply with a non-proliferative phenotype, which is highly motile due to the ‘Go or Grow’ mechanism. On the contrary,
high oxygen level favours the occurrence of the proliferative phenotype which is non-motile due to the migration/proliferation
dichotomy.
been interested in the effect of the ‘Go or Grow’ mechanism on glioma cell diffusion, analysed by means
of a continuous random walk model. Finally, in a recent work (Tektonidis et al., 2011), the ‘Go or Grow’
mechanism has been identified as a central mechanism for the reproduction of in vitro glioma tumour
invasion data. However, none of the existing studies have tested our hypothesis: the response of the
‘Go or Grow’ mechanism to hypoxia may trigger the switch from a highly proliferative to an invasive
phenotype.
To test and analyse our hypothesis, we use a lattice-gas cellular automaton (LGCA). Our LGCA
models a phenotypically homogeneous, avascular tumour growing in a homogeneous oxygen con-
centration field. In our model, the cells accomplish two key processes: (i) cells execute an unbiased
random walk and (ii) cell proliferation is influenced by the local oxygen concentration. The pheno-
type of the cells is controlled by a single-model parameter, which represents the ratio between motil-
ity and proliferation rates. Varying the oxygen concentration allows us to identify the fittest tumour
phenotype. In this paper, fitness is characterized by the total number of tumour cells, i.e. offsprings,
after a certain time interval. The simplicity of the model allows numerical and analytical
investigations. In the following, we collect the most important biological implications of our
study:
• We challenge the widely accepted theory that mutations are responsible for any phenotypic change
involved in tumour progression. Our analysis suggests that the response of the microscopic ‘Go or
Grow’ mechanism to hypoxia, i.e. oxygen shortage, can trigger the switch from a proliferative to a
motile phenotype and vice versa (Fig. 1).
• For each oxygen level, there exists a dominant (fittest) tumour cell phenotype that corresponds to a
certain ratio of proliferation/migration rates.
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• Finally, our model exhibits the non-intuitive behaviour that invasive phenotypes, which show
microscopically low proliferation and high motility, can produce more offsprings than phenotypes
with much higher proliferation rates under certain microenvironmental circumstances.
In Section 2, we answer the question why mutation-based explanations fail in the case of glioma
tumour recurrence and why we need an alternative hypothesis. Then, we test this hypothesis with an
LGCA model that describes a growing tumour cell population. In particular, we introduce the assump-
tions of our model and we discuss the biological relevance of the model parameters. Then, we present
the numerical results of the model simulations. Moreover, we determine the model’s macroscopic be-
haviour, which corresponds to the collective behaviour of the tumour cell colony, through a multiscale
Chapman–Enskog approach. Finally, in the last section, we critically discuss the results and we elaborate
clinical implications of our theoretical analysis.
2. Why not mutations?
In the introduction of this study, we challenge the prevailing view that ‘primarily’ mutations drive the
cancer evolution. We evidence theoretically that a mutation-based hypothesis alone cannot explain the
progression of all tumours by identifying an appropriate counterexample. A particularly
interesting counter-paradigm is the recurrence of GBM tumours after extensive resection (Hatzikirou
et al., 2005), where a mutation-based hypothesis fails to explain the short time span until the tumour’s
recurrence.
It is known that glioma tumours even after extensive resections, of almost 99% of the tumour mass,
fully recur in less than six months (Fig. 2). Typically, a full-grown GBM tumour containing 109 cells
(corresponds to a tumour diameter larger than 1cm) after surgery can be reduced down to ∝ 106–107
cells. These remnant glioma cells are not resected because they have escaped far away from the bulk
of the tumour (Fig. 3). These cells typically belong to the invasive phenotype. According to the migra-
tion/proliferation dichotomy, highly motile cells should exhibit low proliferation rates. The question that
arises is how these invasive tumour cells are able to regenerate the initial tumour in a very short time. In
the following, we test if a mutation-driven phenotypic change is sufficient to support the recurrence of
the initial tumour within a time span less than that of six months.
Firstly, we develop a simple tumour model with two phenotypes—populations, a proliferative ρp(t)
and an invasive ρi(t) one, respectively. The cells that belong to the invasive phenotype proliferate
FIG. 2. T1-weighted contrast-enhanced coronal magnetic resonance imaging (MRI) of recurrent glioblastoma. Left: T1-weighted
contrast-enhanced coronal MRI section showing the resection cavity in the right parietal lobe, 3 months postoperatively. There
is no evidence of tumour recurrence. Middle: corresponding MRI of the same patient, 6 months postoperatively, clearly showing
tumour recurrence (=hyperintense or white mass). Right: control MRI, 9 months postoperatively, showing tumour extension
beyond the previous resection cavity along the cerebral white matter. Images are courtesy of Bonn university hospital.
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FIG. 3. Sketch of pre- and postoperative scenario of a glioblastoma tumour. In the preoperative state, a GBM tumour consists of
an inner core of proliferative cells and an outer ring of invasive tumour cells (for simplification the necrotic core is neglected).
After a gross total resection, the core part of the tumour has disappeared but some cells of the invasive zone stay intact. These
cells are assumed to be responsible for tumour recurrence.
FIG. 4. Schematic representation of mutation-driven phenotypic changes (from the proliferative to the invasive phenotype). Cells
that belong to the proliferative population (ρp) undergo mitosis and the newborn cells (rpρp) are subject to mutation events. The
mutation of the appropriate combination of genes leads to the change of phenotype in mrpρp cells.
much less than the proliferative ones, i.e. the invasive proliferation rate is less than the proliferative
one, ri < rp. We assume that mutations are responsible for the change of phenotypes, and the rate of
change of phenotypes depends solely on the mutation rate. The mechanism of mutation-driven pheno-
typic changes is depicted in Fig. 4. In particular, let cells that belong to j th population undergo mitosis
with a constant rate r j . Mutations occur in the newborn cells of population j and the proportion of cells
that change to phenotype k is m jr j p j , where j 6= k and j, k ∈ {p, i}. It is plausible to consider that
mi = mp = m since there is no reason to assume that mutations favour just one direction. The following
system of equations describes the time evolution of the two phenotypes:
dρp
dt
=
proliferation︷︸︸︷
rpρp +
gain i→p︷ ︸︸ ︷
mriρi −
loss p→i︷ ︸︸ ︷
mrpρp −
death︷︸︸︷
dpρi, (2.1)
dρi
dt
=
proliferation︷︸︸︷
riρi +
gain p→i︷ ︸︸ ︷
mrpρp −
loss i→p︷ ︸︸ ︷
mriρi −
death︷︸︸︷
diρi . (2.2)
The total tumour population at time t is given by the sum of the two phenotypes, i.e. ρ(t) = ρp(t)+ρi(t).
Please note that the above model ‘overestimates’ the total tumour growth for long times. However, this
simple model suffices to demonstrate our hypothesis. In the following, we investigate some resection
scenarios.
Let us assume that a GBM tumour of 109 cells is resected up to 99.9%, i.e. the postoperative glioma
population counts up to 106 invasive tumour cells, i.e. the initial conditions after the resection are
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TABLE 1 Parameters for the mutation model. The proliferative rates of the invasive phe-
notype found in Stein et al. (2007) refer to an in vitro culture of glioma cells. In Giese et al.
(2003), the invasive phenotype exhibits lower apoptotic rates than the proliferative one. Here,
we assume one order of magnitude difference between the two apoptotic rates
Parameter Notation Value Reference
Mitotic rate of proliferative phenotype rp 10−1 days−1 Spencer et al. (2004)
Mitotic rate of invasive phenotype ri 10−2 days−1 Stein et al. (2007)
Apoptotic rate of proliferative phenotype dp 10−2 days−1 Spencer et al. (2004)
Apoptotic rate of invasive phenotype di 10−3 days−1 Giese et al. (2003)
(rp(0), ri(0)) = (0, 106), where t = 0 is the resection time. From the literature, we can determine,
approximately, the values of the mitotic and apoptotic rates for both phenotypes (Table 1).
Firstly, we assume that no phenotypic changes are required to achieve full recurrence, i.e. m = 0. In
this limit case, we investigate if the invasive cells alone are able to reproduce the resected tumour. After
180 days, the total population accounts for ρ(t = 180) ∝ 107 cells, i.e. the recurrent tumour is two
orders of magnitude smaller than the initial one. Therefore, we conclude that for the full tumour recur-
rence, in a time interval of 180 days, the contribution of proliferative cells is required, i.e. the occurrence
of phenotypic changes of tumour cells from the invasive to the proliferative phenotype (m > 0).
Now, our aim is to determine the minimal value of the phenotypic change ratem, based on mutations,
that implies a fully recurrent tumour within six months t = 180 days. From the model, we calculate the
minimal rate that allows for a full recurrence as mmin = 10−3 changes/cell division. However, such
a phenotypic change rate based on mutations is completely unrealistic. The probability of randomly
mutating a specific combination of genes, that is related to a specific phenotypic change, is very low.
For example, if we assume that changing a phenotype requires the mutation of N genes out of 30000
(approximate total number of genes in humans), then the probability of this phenotypic change is p =
1
/(
3× 104
N
)
< 10−4. In particular, let us assume that the ‘minimal’ requirement that a tumour cell
switches phenotype is a point mutation (N = 1), i.e. p = 1/30000 ∝ 10−4. In the literature, it is
assumed that the ‘maximum mutation rate’ is 0.01 mutation/gene/cell division (Spencer et al., 2004).
Therefore, the maximum phenotypic change rate is estimated asmlit = {rate of finding the right gene}×
{rate of mutations per gene} ∝ 10−4 × 10−2 = 10−6, i.e. three orders of magnitude larger than mmin.
Thus, this fact leads us to the conclusion that the switch between proliferative and invasive phenotype
cannot be ‘only’ mutation driven. Consequently, we can assume that a further mechanism should be
responsible for this phenotypic change. At this point, we would like to remind that we have used a
model that overestimated the growth and the upper bounds of the related parameters. Even under these
assumptions, the overestimated tumour growth of our model cannot explain the clinically observed
recurrence solely on the basis of mutations. In the following, we develop an LGCA to test our hypothesis
that the response of the ‘Go or Grow’ mechanism to hypoxia, i.e. oxygen shortage, can trigger the switch
from a proliferative to a motile phenotype and vice versa.
3. The LGCA model
3.1 The LGCA concept
In this study, we use a special type of cellular automaton, called LGCA. The strength of the LGCA
method lies in unravelling the potential effects of movement and interaction of individuals (e.g. cells).
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In traditional cellular automaton models, the implementation of individual movement is not straight-
forward, as one node in the lattice can typically contain only one individual. Consequently, movement
of individuals can cause, e.g. collisions when two individuals want to move into the same empty node.
However, classical cellular automata tackle the same problem in different ways, where several of them
are described in Boccara (2004). In a lattice-gas model, this problem is avoided by having separate
channels for each direction of movement. The channels specify the direction and magnitude of move-
ment, which may include zero velocity (resting) states. For example, a square lattice has four non-zero
velocity channels and an arbitrary number of rest channels. Additionally, LGCA impose an ‘exclusion
principle’ on channel occupation, i.e. each channel may at most host one individual.
Typically, the transition rule of an LGCA, that defines the automaton dynamics, can be decomposed
into two steps (operators). An ‘interaction’ step updates the state of each channel at each lattice site. For
instance, individuals may change their velocity state (reorientation) and appear or disappear (kinetics)
as long as they do not violate the exclusion principle. In the ‘propagation’ step, individuals move syn-
chronously into the direction and by the distance specified by their velocity state. The propagation step
is deterministic and conserves mass and momentum. Synchronous transport prevents individual colli-
sions which would violate the exclusion principle (other models have to define a collision resolution
algorithm). LGCA models allow parallel synchronous movement and fast updating of a large number of
individuals.
3.2 Nomenclature and definitions
We consider an LGCA defined on a 2D regular lattice L = L1 × L2 ⊂ Z2, where L1 and L2 are the
lattice dimensions. Tumour cells move on the discrete lattice with discrete velocities, i.e. they hop at
discrete time steps k ∈ N from a given node to a neighbouring one, as determined by the ‘single cell
speed’. A set of velocity channels (r, ci ), i = 1, . . . , b, is associated with each node r ∈ L ⊂ Z2
of the lattice. The parameter b is the ‘coordination number’, i.e. the number of velocity channels on a
node which coincides with the number of nearest neighbours on a given lattice. The set of velocities
for the square lattice as considered here is represented by the 2D channel velocity vectors c1 =
(
1
0
)
,
c2 =
(
0
1
)
, c3 =
(−1
0
)
, c4 =
(
0
−1
)
. In each of these channels, we consider an exclusion principle,
i.e. we allow at most one cell per channel. We denote by b˜ = b + β the total number of channels per
node which can be occupied simultaneously, where β is the number of channels with zero velocity,
the rest channels ci =
(
0
0
)
, i = b + 1, . . . , b˜. We represent the channel occupancy by a Boolean
random variable called ‘occupation number’ ηi (r, k) ∈ {0, 1}, where i = 1, . . . , b˜ for cancer parti-
cles, r = (rx , ry) ∈ L ⊂ Z2 the spatial variable and k ∈ N the time variable. The b˜-dimensional
vector
η(r, k) := (η1(r, k), . . . , ηb˜(r, k)) ∈ S
is called ‘node configuration’ and S = {0, 1}b˜ the automaton ‘state space’. ‘Node density’ is the total
number of cells present at a node r ∈ L and denoted by
n(r, k) :=
b˜∑
i=1
ηi (r, k).
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3.3 The microenvironment: oxygen concentration
We assume that the number of tumor cells supported in a node is proportional to the available oxygen
on that node. In this study, oxygen is assumed to be homogeneously distributed on the lattice and re-
plenished to a given constant value at each time step. We define the parameter C ∈ [0, b˜] that represents
the ‘maximum node occupancy’ which depends on the oxygen availability. We would like to stress that
the parameter C plays a crucial role.
3.4 Tumour cell dynamics
In our model, cell dynamics are modelled by a set of automaton rules (operators): propagation (P), re-
orientation (O) and kinetics (R). In particular, the reorientation and the propagation operators dictate
the cell transport and the cell kinetics operator controls the change of the local number of cells on a
node through a birth/death process. The composition R ◦O ◦P of the three operators is applied indepen-
dently at every node of the lattice at each time step. The cell dynamics are subjected to the following
assumptions:
A1 Tumour cells move randomly.
A2 Mitotic and apoptotic rates depend on the local cell density.
A3 The ‘Go or Grow’ mechanism influences the birth/death process (mitosis/apoptosis) of the tu-
mour cells (for details see below).
3.4.1 Propagation (P) Cell translocation on the substrate is modelled by the propagation step. The
propagation step is deterministic and is governed by an operator P. By the application of P, all cells are
transported simultaneously to nodes in the direction of their velocity, i.e. a cell residing in channel (r, c i)
at time k ∈ N0 is moved to a neighbouring channel (r + mc i, c i) during one time step. Here, m ∈ N
determines the speed and mci is the translocation of the cell. The cells residing on the rest channel do
not move as they have zero velocity. In terms of occupation numbers, the state of a channel (r+mc i, c i)
after propagation becomes
ηPi (r+ mc i, k + τ) = ηi(r, k),
where τ is the time step of the LGCA. We note that the propagation operator is mass and momentum
conserving.
3.4.2 Reorientation (O) The reorientation operator is responsible for the redistribution of cells within
the velocity channels of a node, providing a new node velocity distribution. In this paper, we assume
that individual cells perform random walks. This implies a random redistribution of the cells among the
node’s channels. The stationary1 transition probabilities are
P(η → ηO)(r, ∙) = 1
Z
δ
(
n(r, ∙), nO(r, ∙)
)
, (3.1)
where the normalization factor Z = ∑ηO(r,∙) δ(n(r, ∙), nO(r, ∙)) corresponds to the equivalence class
defined by the value of the preinteraction node density n(r, ∙). The Kronecker δ assumes the mass
conservation of this operator. Our choice for the reorientation operator is one out of various possible
1The transition probabilities are independent of the time variable (indicated by a dot in the respective formulae).
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ways to describe random motion by means of LGCA (Chopard & Droz, 1998; Deutsch & Dormann,
2005). The particular choice of the rule greatly simplifies the subsequent analytical derivation of the
equations describing the meso- and macroscopic evolution of the automaton.
3.4.3 Cell kinetics (R) In our model, tumour cells are allowed to proliferate and to undergo apoptosis.
The migration/proliferation dichotomy plays a crucial role in the definition of these processes. Moreover,
the oxygen supply influences the individual cell’s apoptotic rate. In detail, we define a stochastic birth–
death process for the tumour cells as follows:
• Mitosis: Abnormal proliferation is a principle characteristic of cancer cells. Cells proliferate accord-
ing to a ‘carrying capacity-limited’ proliferation mechanism (alternatively called ‘space-inhibited
proliferation’). The carrying capacity density reflects cell crowding effects, i.e. cells proliferate when
the cell density is below carrying capacity but proliferation ceases when the cell density reaches the
capacity density. For the creation of a new cell on a node, the existence of at least one cell and at
least one free channel are required (A2), i.e.:
Ri (r, ∙) = ξi (r, ∙)(1− ηi (r, ∙)), (3.2)
where ξi (r, ∙)’s are random Boolean variables, with∑b˜i=1 ξi (r, ∙) = 1, and the corresponding prob-
abilities are
P(ξi (r, ∙) = 1) = rm
∑b˜
i=1 ηi (r, ∙)
b˜
. (3.3)
Here, rm is the probability of occupying a channel, if at least one cell exists on the node. The pro-
liferation rate rm cannot be deliberately chosen. Growth of tumour cells is dictated by the ‘Go or
Grow’ mechanism (A3), which means that cells are allowed to proliferate only when they rest, i.e.
when they are positioned on a rest channel. Therefore, we can conclude that the proliferation rate is
proportional to the number of rest channels β, i.e.
rm = βrˉm, (3.4)
where rˉm is a base cell proliferation rate.
• Apoptosis: We assume that oxygen availability implies a maximum node occupancy C , i.e. the node
oxygen supply cannot support more than C living tumour cells. Thus, we define an apoptotic rate for
each tumour cell that ensures the existence of at most C cells per node:
rd = b˜ − C
b˜
βrˉm, (3.5)
where the factor b˜−C
b˜
is a dimensionless quantity. Note that the apoptotic rate is monotonically
increasing with respect to β, i.e. the number of rest channels.
Both mitotic and apoptotic cell rates depend on the number of rest channels β. We will later demon-
strate that the parameter β (number of rest channels) can be interpreted as the ratio of motility versus
proliferation ‘strength’ which characterizes the tumour cell phenotype. Moreover, cells with prolifer-
ative phenotypes, i.e. large β, possess larger apoptotic rates and cells with invasive phenotypes lower
apoptotic rates (see (3.5)), respectively. This interpretation is consistent with experimental observations
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which indicate that, due to the migration/proliferation dichotomy (A3), invasive cells with ‘low propen-
sity to proliferate also may be resistant to apoptosis’ (Giese et al., 2003).
4. Simulations
In this study, the principle question concerns the regulation mechanisms that trigger the switch from
proliferative to invasive phenotypes. The ‘Go or Grow’ mechanism imposes a relation between cell
motility and proliferation. The crucial quantity is the total number of cells after a given period of time
since this quantifies the success of a phenotype for a given oxygen level, i.e. defines the ‘fitness’ of
the tumour in a given ‘environment’. The control parameters are β as a phenotype parameter and
C as an environmental parameter. The systematic variation of β allows us to identify the most suc-
cessful phenotype in an environment characterized by C . In the following, we provide the simulation
results.
Firstly, we have simulated our LGCA model on a 2D 500×500 lattice for 1000 time steps. In Fig. 5,
we show simulations for variations of the number of rest channels β = {2, . . . , 8} (and b˜ = {6, . . . , 12},
respectively), for fixed maximum occupancy C = b˜ and for fixed base proliferation rate rˉm = 0.05.
The initial condition comprises just a small disc in the center. From the simulations, we conclude the
following:
• The pattern evolving from a localized initial occupation is an isotropically growing disc.
• Simulations indicate a moving front along which the occupancy of the initially empty nodes is in-
creasing from zero cells to the maximum occupancy C .
• Increasing the number of rest channels, we observe that the emerging disc decreases in size since the
cells become less motile. Moreover, the infiltration zone, i.e. the region between the periphery of the
FIG. 5. Left: Typical tumour pattern after 1000 time steps. For maximum occupancy C = b˜ and for a fixed proliferation rate
rm = 0.05 and with β = 4 rest channels (and b˜ = 8). The initial tumour mass was located in the center of the lattice. The
colours encode the node density. Right: Infiltration radius against phenotype. For maximum occupancy C = b˜ and for a fixed base
proliferation rate rm = 0.05, we show how the invasive radius varies by increasing the number of rest channels β, i.e. by making
the tumour cells more proliferative. We observe a linear decrease of the infiltration radius as β increases.
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disc and the beginning of the core (maximum occupancy region) shrinks as β increases (right panel
of Fig. 5).
In order to get a deeper insight into the effects of the ‘Go or Grow’ mechanism on tumour pro-
gression, we use a different simulation set-up. We consider a ‘tube’, especially a 2000 × 100 lattice
with periodic boundary condition on the L2-axis and a thin stripe of tumour cells as initial condition.
A typical simulation time lasts for 2000 time steps. The result of our simulations is a propagating 2D
front along the L1-axis, mimicking a ‘growing tube’. This setting has the following advantages:
• We project our system to 1D by averaging the concentration profile along the L2-axis, i.e. n(rx , k) =
1
|L2|
∑
ry∈|L2| n(r, k).
• The front is well defined as the mean position of the foremost cells.
• The interface diffusion, i.e. the front width variation, relaxes faster to an equilibrium than in the case
of discoidal 2D evolution.
• The front profile relaxes to an almost time-invariant shape, which translates almost uniformly along
the L1-axis.
We simulate our system for different combinations of the parameters β = {1, . . . , 6} and C = 6, 7, 8
(we fix the base proliferation rate to rˉm = 0.05). For these parameter combinations, we measure the
total number of cells after the above-mentioned typical simulation time. The most interesting results are
the following:
1. The total number of cells evolves linearly in time.
2. For each C isocline, i.e. ‘isonutrient curve’, we obtain a maximum value of the total number of
cells for a unique β (Fig. 6). This implies that the fittest phenotype for a given oxygen supply C
is unique.
3. Figure 6 shows that under hypoxic conditions, i.e. after lowering the oxygen supply C , the fittest
phenotype corresponds to the invasive one, i.e. higher motility and lower proliferation (low β).
4. Moreover, in Fig. 6, we observe that a proliferative population (high β) can give rise to a lower
number of offspring cells than populations of motile populations, i.e. low β, with lower prolif-
erative rates. This result shows that the best strategy of cells in scarce environments is the faster
exploration of new territories and the lowering of the proliferation rates.
Observations (2) and (3) confirm our main hypothesis that the response of the ‘Go or Grow’ mech-
anism to a hypoxic environment favours the emergence of invasion.
At this point, we return to the case of glioma tumour recurrence.We have demonstrated that mutation-
based phenotypic changes alone are insufficient to explain the speed of glioma recurrence. Therefore, an
alternative hypothesis for the mechanisms that control the tumour phenotypic transitions is required. We
claim that the switch from a proliferative to a motile phenotype is controlled by the interplay of the ‘Go
or Grow’ mechanism and the local oxygen supply. In particular, we claim that an increase in the oxygen
supply can accelerate the transition rates from an invasive to a proliferative phenotype (Fig. 6). Espe-
cially in the case of the tumour bulk resection, the oxygen availability rises abruptly back to normoxic
levels. This can trigger our proposed mechanism and consequently increase the transition rates towards
a proliferative phenotype. Finally, this leads to an increase of the proportion of proliferative cells and
the acceleration of the recurrent tumour’s growth rates.
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FIG. 6. Optimal tumour strategy depending on microenvironmental conditions. On the x-axis, we vary the parameter β, which
characterizes the tumour cell phenotype, ranging from motile populations (β small) to proliferative ones (β large). Each of
the curves represents an isonutrient, i.e. the behaviour of the population under the same oxygen availability. We observe that
each isonutrient curve has a maximum, which corresponds to the best fitted phenotype (β) in this specific environmental
setting.
5. Analysis
In this section, we provide the results of the mean-field analysis of our model which leads to partial
differential equation that describes the collective behaviour of our LGCA. The goal is to derive an
average cell diffusion coefficient and proliferative rate, which together define the average phenotype of
the population. This mathematical analysis allows for the generalization of our numerical results. Note
that the mathematical details of our analysis can be found in the “Supplementary material” of our paper.
In order to derive a macroscopic description, corresponding to the collective behaviour of the whole
tumour cell population, we use the Chapman–Enskog methodology (Chopard & Droz, 1998). Here, we
define the ‘mean node density’ as
ρ(r, k) = 〈n(r, k)〉.
Note that the average 〈∙ ∙ ∙ 〉 is defined over an arbitrary node distribution at a given time k. The main
assumption of our method is the diffusive scaling of space and time, i.e.
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x = ²r and t = ²2k, (5.1)
where (x, t) are the continuous variables as ² → 0. Working out the mathematical details, we derive a
macroscopic description of our system which belongs to the class of Fisher–Kolmogorov equations:
∂tρ = m
2
b˜τ
∇2ρ + βrˉmC
τ b˜
ρ(1− ρ). (5.2)
Note that (5.2) is valid only for very small mitotic rates, i.e. rˉm ¿ 12. The macroscopic proliferation
and motility rates are identified by r˜m and D, respectively,
r˜m = βrˉmC
τ b˜
, (5.3)
D = m
2
(b + β)τ . (5.4)
We observe that the ‘Go or Grow’ mechanism is manifested in the above macroscopic coefficients
since the proliferation rate (5.3) is monotonically increasing with respect to the number of rest channels
(the more resting cells, the greater the proliferation rate) and the diffusive coefficient (5.4) is monotoni-
cally decreasing (more resting cells induce reduced motility). Finally, using (5.3) and (5.4), we confirm
that the parameter β characterizes the population phenotype since it is proportional to the ratio of pro-
liferation and diffusion rate, i.e.
β ∝ r˜m
D
. (5.5)
6. Discussion
Here, we have investigated potential mechanisms that may promote the progression from benign neo-
plasms to malignant invasive tumours characterized by high migration rates. Traditionally, the tumour
progression is assumed to be mutation driven. Here, we propose that the “Go or Grow” mechanism
and oxygen shortage in a growing tumour are sufficient to trigger the switch from a proliferative to an
invasive phenotype in some cells. Our hypothesis can be considered as a consequence of phenotypic
plasticity and microenvironmental effects on the emergence of tumour phenotypes (Anderson et al.,
2006; Merlo et al., 2002; Quaranta et al., 2008). In particular, a correlation of a hypoxic environment
with the emergence of invasive phenotypes has only been observed so far in game theoretical studies
based on mutation-driven evolution, such as Basanta et al. (2008a,b). Recently, in the biomathematical
literature, several studies discuss the variations of migration and proliferation with respect to tumour
progression (Chauviere et al., 2009; Enderling et al., 2009; Thalhauser et al., 2009; Wang et al., 2009).
The need for an alternative hypothesis is prominent in the case of GBM recurrence after surgery. Our
investigation showed that the sole assumption of mutation-driven tumour progression is insufficient to
explain the fast GBM recurrence after resection. To test our new hypothesis, we set up an LGCA model.
We represent the tumour phenotype by a single parameter β corresponding to the ratio between prolif-
erative and motility rates. The tumour’s microenvironment is represented by the oxygen concentration
C , which is a crucial model parameter that influences the proliferative ability and the apoptotic rate
2This is a result of the scaling of the growth term, i.e. rm = ²2r˜m ¿ 1, where r˜m ∝ O(1).
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of tumour cells. The parameter β plays a key role in the modelling of the ‘Go or Grow’ mechanism
since its value is related to the proliferation rate of the cells. Interestingly, the apoptotic rate (3.5) is
monotonically increasing with respect to the parameter β, implying that invasive cells (low β) with low
propensity to proliferate also may be resistant to apoptosis (Giese et al., 2003). Finally, our model ex-
hibits the intriguing behaviour that invasive phenotypes, which show microscopically low proliferation
and high motility, may produce more offspring than phenotypes with much higher proliferation rates.
This may explain, in part, the rapid expansion rates of some invasive tumours.
6.1 Biological evidence
Hypoxia is a common feature of most cancers. Recently, several biological studies have linked hypoxia
to the invasive behaviour of tumours. In particular, it has been observed that hypoxia is responsible for
down-regulation of cadherins, resulting is the disruption of cell–cell adhesive interactions, the promotion
of invasive and metastatic behaviour (Sullivan & Graham, 2007) and the reduction of the proliferative
activity (Daruwalla & Christophi, 2006). These biological observations support our hypothesis that hy-
poxia triggers the switch from a proliferative to an invasive phenotype.
The dependence of the invasion/proliferation switch on the oxygen level suggests that the regulatory
network responsible for the control of mitosis and migration may share common signalling pathways
with the oxygen uptake network. Candidate molecular mechanisms that link hypoxia to invasive be-
haviour have already been suggested. In particular, it has been found that in glioma cell lines, hypoxia
induces the expression of the c-Met protein which enhances glioma cell migration and invasiveness
(Eckerich et al., 2007). The hypoxia induced factor protein has been recognized as a key molecule
responsible for the hypoxia-induced tumour invasiveness (Fujiwara et al., 2007).
Finally, a recent publication Godlewski et al. (2010) qualitatively confirms our main result, i.e.
that migration/proliferation dichotomy is regulated by the levels of the metabolic stress. In particular,
they claim that abundance of nutrients allows for the high expression of miR-451 which promotes high
proliferation. On the other hand, in scarce environments miR-451 levels are decreased slowing the pro-
liferation and enhancing the migration of the glioma cells.
6.2 ‘Go or Grow’ strategies in nature
Interestingly, in ecology, we can identify a correlation of increased motility and species extinctions
(Viswanathan et al., 2008). In particular, high motility strategies seem to confer a vital advantage in the
limit of low densities—at the edge of extinction. Actually, empirical data indicate that some insects (Sis-
terson & Averill, 2002) and fish (Lamine et al., 2005) near starvation increase their movement intensity
and diffusiveness in the search for food when compared to their foraging activity under normal condi-
tions. Under scarce environmental conditions, species presenting such behaviour can have an adaptive
advantage.
Finally, also in the field of social psychology, the evolutionary benefits of a motile strategy have
been observed. In particular, Aktipis (2004, 2008) have analysed a so-called ‘walk away’ strategy that
promotes the evolution of cooperation and confers significant advantages to the fitness of the whole
population. It is based on the notion that individuals can leave regions, partners or groups that are
insufficiently productive, which can be done by simply coopting foraging adaptations. In general, we
can claim that the ‘Go or Grow’ strategy is a cognitively simple, evolutionary ancient, phylogentically
widespread and well known in nature.
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6.3 Therapy
Clinically, hypoxia correlates with an adverse prognosis and renders tumour cells more resistant to
radiation and chemotherapy (Daruwalla & Christophi, 2006; Kizaka et al., 2003). Hence, improving
tumour oxygenation may result in better treatment outcomes. This paradigm has been investigated in
numerous clinical studies (Daruwalla & Christophi, 2006). Our results point to a different therapeutic
paradigm that could potentially be applied to many cancers. Certain brain tumours (gliomas) are a
typical example for invasive and diffusive tumours. Gliomas not only proliferate but also actively invade
the surrounding brain parenchyma. The surgical resection of these diffusive tumours will not result in
a cure since the cancer cells have already invaded the surrounding healthy and functional brain tissue.
This leads to recurrence of the tumour in all but a few cases. The prognosis for patients suffering from
malignant gliomas is very poor. It has been suggested (Giese et al., 2003) that invasive glioma cells
are able to revert to a proliferative cellular program and vice versa, depending on the environmental
stimuli. Our model suggests that reactivation of the proliferative program of invasive tumour cells by
increasing oxygen tension (medical term for oxygenation) in the tumour will enhance the dominance of
proliferative over the motile phenotypes. The result will be a tumour characterized by a more confined
growth pattern and lower expansion speed. The analysis of our model shows that the switch from a
motile to a proliferative phenotype will not lead to a faster growing neoplasm. Quite to the contrary,
overall tumour growth will slow down. Hence, this therapeutical strategy may directly improve the
patient’s prognosis. It may also allow for more radical and therefore successful tumour resection. Finally,
Gatenby proposed a similar perspective in designing new therapeutic strategies for controlling tumour
growth instead of trying to eradicate the tumour cells (Gatenby, 2009).
Supplementary material
Supplementary material is available at http://www.imammb.oxfordjournals.org/.
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